Dexamethasone, High-dose Cytarabine, and Carboplatin (DAC) Combination is Effective for Childhood Advanced Large-Cell Non-Hodgkin Lymphoma

BACKGROUND: To purpose of this study was to evaluate the activity and toxicity of dexamethasone, high-dose cytarabine, and carboplatin (DAC) combination therapy in children with newly diagnosed large-cell non-Hodgkin lymphoma (NHL) and to estimate the event-free and overall survival rates achieved w...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Sandlund, John T., Santana, Victor M., Hudson, Melissa M., Onciu, Mihaela, Behm, Frederick G., Head, David, Murry, Daryl J., Ribeiro, Raul, Wallace, Dana, Rencher, Renee, Pui, Ching-Hon
Formato: Artigo
Idioma:Inglês
Publicado: 2008
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2975596/
https://ncbi.nlm.nih.gov/pubmed/18618501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.23630
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares